Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
2376
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.03M | ﹤0.01% |
154,754
-25,503
| -14% | -$485K |
|
|
QVCGA
2377
DELISTED
QVC Group Inc Series A
QVCGA
| $3.03M | ﹤0.01% |
2,808
-214
| -7% | -$225K |
|
|
WPG
2378
DELISTED
Washington Prime Group Inc.
WPG
| $3.03M | ﹤0.01% |
46,034
+13,932
| +43% | +$964K |
|
2379
Wendy's
WEN
$1.44B
| $3.02M | ﹤0.01% |
176,282
+125,104
| +244% | +$2.19M |
|
|
NAV
2380
CALL
DELISTED
Navistar International
NAV
| $3.02M | ﹤0.01% |
78,300
-10,800
| -12% | -$450K |
|
|
WFT
2381
DELISTED
Weatherford International plc
WFT
| $3.01M | ﹤0.01% |
1,111,489
+562,840
| +103% | +$1.65M |
|
2382
Southwest Gas
SWX
$6.63B
| $3.01M | ﹤0.01% |
38,088
+30,828
| +425% | +$2.44M |
|
2383
Littelfuse
LFUS
$11.5B
| $3.01M | ﹤0.01% |
15,209
-20,984
| -58% | -$4.62M |
|
|
MDCO
2384
DELISTED
Medicines Co
MDCO
| $3M | ﹤0.01% |
100,397
+51,675
| +106% | +$1.95M |
|
2385
CALL
Steel Dynamics
STLD
$37.8B
| $3M | ﹤0.01% |
66,400
-36,500
| -35% | -$1.68M |
|
|
SRG
2386
Seritage Growth Properties
SRG
$135M
| $3M | ﹤0.01% |
63,131
+18,644
| +42% | +$883K |
|
|
MASI
2387
DELISTED
Masimo
MASI
| $3M | ﹤0.01% |
24,049
-62,828
| -72% | -$6.97M |
|
2388
PUT
Match Group
MTCH
$8.45B
| $2.99M | ﹤0.01% |
51,700
+10,100
| +24% | +$473K |
|
2389
PUT
Microchip Technology
MCHP
$44B
| $2.99M | ﹤0.01% |
75,800
-6,600
| -8% | -$292K |
|
2390
Cabot Corp
CBT
$4.49B
| $2.99M | ﹤0.01% |
47,661
+37,601
| +374% | +$2.42M |
|
2391
MarketAxess Holdings
MKTX
$5.72B
| $2.99M | ﹤0.01% |
16,742
+9,468
| +130% | +$1.82M |
|
2392
PUT
Stanley Black & Decker
SWK
$15.7B
| $2.99M | ﹤0.01% |
20,400
+11,800
| +137% | +$1.68M |
|
2393
Kulicke & Soffa
KLIC
$4.76B
| $2.99M | ﹤0.01% |
125,222
+27,714
| +28% | +$719K |
|
2394
Bio-Techne
TECH
$11.2B
| $2.98M | ﹤0.01% |
58,468
-123,996
| -68% | -$5.49M |
|
|
GBT
2395
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.98M | ﹤0.01% |
78,400
-15,300
| -16% | -$678K |
|
|
EXAS
2396
DELISTED
Exact Sciences
EXAS
| $2.98M | ﹤0.01% |
37,705
-210,563
| -85% | -$13.7M |
|
2397
Itron
ITRI
$4.52B
| $2.97M | ﹤0.01% |
46,340
+28,853
| +165% | +$1.82M |
|
2398
Neurocrine Biosciences
NBIX
$16.5B
| $2.97M | ﹤0.01% |
24,182
+1,758
| +8% | +$199K |
|
|
SNBR
2399
DELISTED
Sleep Number
SNBR
| $2.97M | ﹤0.01% |
80,654
+31,351
| +64% | +$1.02M |
|
2400
Hecla Mining
HL
$11.9B
| $2.96M | ﹤0.01% |
1,060,751
+750,634
| +242% | +$2.29M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.